
Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection — ramping up the race to begin limited vaccinations as the coronavirus rampage worsens.
from CBC | Health News https://ift.tt/2Jsg4uO
Aucun commentaire:
Enregistrer un commentaire